GC
Luye to provide investors with a dose of diversification
Luye Pharma Group started premarketing a $800m Hong Kong IPO on June 11, with those on the deal confident that investor demand will be red hot.
Arranged by Citi, Citic Securities and UBS, the investor meetings will run for one and a half weeks, after which bookbuilding is scheduled to launch on June 23.
“We’re all predicting this one to go really well because it’s a sector everyone loves,” one banker close to the ...Already a subscriber? Login
Further reading
-
Corp
Vedanta builds war chest for corporate revamp
-
FIG
CDB Leasing takes tight pricing approach, meets goals
-
Corp
Fantasia, Sunac find demand for new bonds
-
Regulation & Policy
China policy and markets round-up: Beijing hones in on green finance, southbound Bond Connect to launch before year-end, BOC, ICBC name new presidents
